vs

Side-by-side financial comparison of CBL & ASSOCIATES PROPERTIES INC (CBL) and CROSS COUNTRY HEALTHCARE INC (CCRN). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $156.4M, roughly 1.5× CBL & ASSOCIATES PROPERTIES INC). CBL & ASSOCIATES PROPERTIES INC runs the higher net margin — 31.3% vs -35.0%, a 66.3% gap on every dollar of revenue. On growth, CBL & ASSOCIATES PROPERTIES INC posted the faster year-over-year revenue change (18.8% vs -23.6%). Over the past eight quarters, CBL & ASSOCIATES PROPERTIES INC's revenue compounded faster (10.1% CAGR vs -21.0%).

CBL & Associates Properties, Inc. is an American real estate investment trust that invests in shopping centers and shopping malls, primarily in the Southeastern and Midwestern United States. The company is organized in Delaware with its headquarters in Chattanooga, Tennessee. Its largest market is Chattanooga, Tennessee. The company's name is based on the initials of its founder, Charles B. Lebovitz.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

CBL vs CCRN — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.5× larger
CCRN
$236.8M
$156.4M
CBL
Growing faster (revenue YoY)
CBL
CBL
+42.4% gap
CBL
18.8%
-23.6%
CCRN
Higher net margin
CBL
CBL
66.3% more per $
CBL
31.3%
-35.0%
CCRN
Faster 2-yr revenue CAGR
CBL
CBL
Annualised
CBL
10.1%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBL
CBL
CCRN
CCRN
Revenue
$156.4M
$236.8M
Net Profit
$49.0M
$-82.9M
Gross Margin
Operating Margin
-30.2%
Net Margin
31.3%
-35.0%
Revenue YoY
18.8%
-23.6%
Net Profit YoY
29.0%
-2109.7%
EPS (diluted)
$1.61
$-2.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBL
CBL
CCRN
CCRN
Q4 25
$156.4M
$236.8M
Q3 25
$139.3M
$250.1M
Q2 25
$140.9M
$274.1M
Q1 25
$141.8M
$293.4M
Q4 24
$131.7M
$309.9M
Q3 24
$125.1M
$315.1M
Q2 24
$129.7M
$339.8M
Q1 24
$129.1M
$379.2M
Net Profit
CBL
CBL
CCRN
CCRN
Q4 25
$49.0M
$-82.9M
Q3 25
$75.4M
$-4.8M
Q2 25
$2.8M
$-6.7M
Q1 25
$8.8M
$-490.0K
Q4 24
$38.0M
$-3.8M
Q3 24
$16.2M
$2.6M
Q2 24
$4.7M
$-16.1M
Q1 24
$50.0K
$2.7M
Gross Margin
CBL
CBL
CCRN
CCRN
Q4 25
Q3 25
20.4%
Q2 25
20.4%
Q1 25
20.0%
Q4 24
Q3 24
20.4%
Q2 24
20.8%
Q1 24
20.4%
Operating Margin
CBL
CBL
CCRN
CCRN
Q4 25
-30.2%
Q3 25
-2.4%
Q2 25
-2.1%
Q1 25
-0.3%
Q4 24
-1.1%
Q3 24
0.9%
Q2 24
-5.7%
Q1 24
0.8%
Net Margin
CBL
CBL
CCRN
CCRN
Q4 25
31.3%
-35.0%
Q3 25
54.2%
-1.9%
Q2 25
2.0%
-2.4%
Q1 25
6.2%
-0.2%
Q4 24
28.8%
-1.2%
Q3 24
12.9%
0.8%
Q2 24
3.7%
-4.7%
Q1 24
0.0%
0.7%
EPS (diluted)
CBL
CBL
CCRN
CCRN
Q4 25
$1.61
$-2.56
Q3 25
$2.38
$-0.15
Q2 25
$0.08
$-0.20
Q1 25
$0.27
$-0.02
Q4 24
$1.22
$-0.13
Q3 24
$0.52
$0.08
Q2 24
$0.14
$-0.47
Q1 24
$-0.01
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBL
CBL
CCRN
CCRN
Cash + ST InvestmentsLiquidity on hand
$42.3M
$108.7M
Total DebtLower is stronger
$2.2B
Stockholders' EquityBook value
$374.9M
$322.8M
Total Assets
$2.7B
$449.0M
Debt / EquityLower = less leverage
5.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBL
CBL
CCRN
CCRN
Q4 25
$42.3M
$108.7M
Q3 25
$52.6M
$99.1M
Q2 25
$100.3M
$81.2M
Q1 25
$100.3M
$80.7M
Q4 24
$40.8M
$81.6M
Q3 24
$65.1M
$64.0M
Q2 24
$57.7M
$69.6M
Q1 24
$57.7M
$5.2M
Total Debt
CBL
CBL
CCRN
CCRN
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.1B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$1.8B
Q2 24
$1.9B
Q1 24
$1.9B
Stockholders' Equity
CBL
CBL
CCRN
CCRN
Q4 25
$374.9M
$322.8M
Q3 25
$351.4M
$408.1M
Q2 25
$289.4M
$412.2M
Q1 25
$295.0M
$418.2M
Q4 24
$323.5M
$419.0M
Q3 24
$308.3M
$424.7M
Q2 24
$308.8M
$433.3M
Q1 24
$324.2M
$462.4M
Total Assets
CBL
CBL
CCRN
CCRN
Q4 25
$2.7B
$449.0M
Q3 25
$2.7B
$538.2M
Q2 25
$2.6B
$553.8M
Q1 25
$2.6B
$576.2M
Q4 24
$2.7B
$589.3M
Q3 24
$2.2B
$597.4M
Q2 24
$2.3B
$602.9M
Q1 24
$2.3B
$648.4M
Debt / Equity
CBL
CBL
CCRN
CCRN
Q4 25
5.79×
Q3 25
6.21×
Q2 25
7.39×
Q1 25
7.29×
Q4 24
6.84×
Q3 24
5.76×
Q2 24
6.00×
Q1 24
5.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBL
CBL
CCRN
CCRN
Operating Cash FlowLast quarter
$249.7M
$18.2M
Free Cash FlowOCF − Capex
$16.1M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
5.10×
TTM Free Cash FlowTrailing 4 quarters
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBL
CBL
CCRN
CCRN
Q4 25
$249.7M
$18.2M
Q3 25
$69.6M
$20.1M
Q2 25
$68.3M
$4.2M
Q1 25
$31.7M
$5.7M
Q4 24
$202.2M
$24.2M
Q3 24
$61.1M
$7.5M
Q2 24
$64.2M
$82.4M
Q1 24
$30.7M
$6.0M
Free Cash Flow
CBL
CBL
CCRN
CCRN
Q4 25
$16.1M
Q3 25
$17.9M
Q2 25
$2.3M
Q1 25
$3.8M
Q4 24
$21.7M
Q3 24
$46.0M
$6.3M
Q2 24
$54.8M
$79.6M
Q1 24
$24.7M
$3.8M
FCF Margin
CBL
CBL
CCRN
CCRN
Q4 25
6.8%
Q3 25
7.2%
Q2 25
0.8%
Q1 25
1.3%
Q4 24
7.0%
Q3 24
36.8%
2.0%
Q2 24
42.2%
23.4%
Q1 24
19.1%
1.0%
Capex Intensity
CBL
CBL
CCRN
CCRN
Q4 25
0.9%
Q3 25
0.9%
Q2 25
0.7%
Q1 25
0.6%
Q4 24
0.8%
Q3 24
12.1%
0.4%
Q2 24
7.3%
0.8%
Q1 24
4.7%
0.6%
Cash Conversion
CBL
CBL
CCRN
CCRN
Q4 25
5.10×
Q3 25
0.92×
Q2 25
24.74×
Q1 25
3.60×
Q4 24
5.32×
Q3 24
3.77×
2.92×
Q2 24
13.54×
Q1 24
614.76×
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBL
CBL

Segment breakdown not available.

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

Related Comparisons